Enabling Novel Pharmaceutical Therapies through 3D-Printing

Aprecia continues its leadership position in the pharmaceutical application of 3D-Printing. Aprecia will be launching its two new platforms later this year that will provide additional benefits in early development FIH clinical as well as small and large scale commercial production. In this presentation, Aprecia will discuss the flexibility and precision these platform provide in delivering novel products to the market.

Continue reading “Enabling Novel Pharmaceutical Therapies through 3D-Printing”

Additive Manufacturing: Unlocking Pharma’s Unmet Challenges

Jae Yoo

A presentation by Jae Yoo, CTO of Aprecia Pharmaceuticals. He is serving as Chief Technology Officer for Aprecia Pharmaceuticals, LLC since August 2018. His 3DP journey started at MIT in the early 1990’s where he developed and used an inkjet printing based 3DP process to fabricate advanced ceramic materials with compositional gradient.

Continue reading “Additive Manufacturing: Unlocking Pharma’s Unmet Challenges”